Tamil Nadu government hospitals report shortages of drugs for premature babies

Several Tamil Nadu government hospitals are facing shortages of surfactant medicines used to help inflate the lungs of premature babies, according to inquiries with hospitals and doctors. The available report does not identify the affected facilities, the scale of the shortfall or its cause.
A number of Tamil Nadu government hospitals are facing a short supply of surfactant medicines used in treating premature babies, The Hindu reported. Surfactants are essential for inflating the lungs of preterm infants who require the therapy. The medicines are used when babies need assistance with lung function, making availability important for centres providing care to premature newborns.
The report said inquiries with a number of hospitals and doctors found that several centres had been experiencing shortages. The supplied information does not identify the hospitals involved, state how many babies have been affected or indicate how long the short supply has continued. It also does not give details of existing stocks, deliveries expected by the hospitals or the reason for the shortage.
No statement from the Tamil Nadu government, health authorities or medicine suppliers was included in the available material. The account does not say whether treatment has been postponed, whether hospitals have obtained supplies from other centres or whether any alternative medicine is being used. It therefore establishes the reported shortage without quantifying its effect on patient care.
Surfactant medicines remain central to the therapy described for preterm babies with the relevant need. The reported concern is that some government hospitals do not have a sufficient supply, while further information about procurement and replenishment was not provided.
This independently written report is based on information supplied by the named publisher. Vertrix News has not independently verified the source report.